TY  - JOUR
AU  - Gonzalez-Mancebo, Daniel
AU  - Becerro, Ana I.
AU  - Rojas, T. Cristina
AU  - Garcia-Martin, Maria L.
AU  - de la Fuente, Jesus M.
AU  - Ocana, Manuel
PY  - 2017
DO  - 10.1002/ppsc.201700116
SN  - 0934-0866
UR  - http://hdl.handle.net/10668/18618
T2  - Particle & particle systems characterization
AB  - Clinical contrast agents (CAs) currently used in magnetic resonance imaging (MRI) at low fields are less effective at high magnetic fields. The development of new CAs is mandatory to improve diagnostic capabilities of the new generation of high field...
LA  - en
PB  - Wiley-v c h verlag gmbh
KW  - contrast agents
KW  - dysprosium fluoride
KW  - holmium fluoride
KW  - magnetic resonance imaging (MRI)
KW  - relaxivity
KW  - In-vivo
KW  - Nahof4 nanoparticles
KW  - Ionic liquids
KW  - Size
KW  - Performance
KW  - Tomography
KW  - Cancer
KW  - Probes
KW  - Metal
KW  - Oxide
TI  - HoF3 and DyF3 Nanoparticles as Contrast Agents for High-Field Magnetic Resonance Imaging
TY  - research article
VL  - 34
ER  -